What are my treatment options for late-stage prostate cancer?
If you have been diagnosed with late-stage prostate cancer or just learned that your cancer has spread outside the prostate, you are still in the game with treatment options.
Prostate cancer marker tests can help you and your healthcare provider rally to the challenge. As you are considering next steps, one PCM test can help you uncover if you may not respond to androgen receptor (AR) targeted therapies.
PCM Tests During Late-Stage Prostate Cancer
PCM tests during late-stage prostate cancer can help determine what treatment options might be most effective.
For men with mCRPC (metastatic castration-resistant prostate cancer), this blood test shows if androgen receptor (AR) targeted therapies could be an effective treatment approach.
Advanced Prostate Cancer FAQs
As you are experiencing late-stage prostate cancer, you may have questions about PCMs, genetic testing, and more. Below is an initial list of frequently asked questions.
A medicine that targets a specific receptor present in some prostate cancers is used to treat qualifying patients with late-stage cancer. This PCM test can help determine if you are a candidate for androgen receptor (AR) targeted therapies.
Prostate cancer biomarkers (PCMs) are molecules found in blood, tissue, or body fluids. PCMs are revolutionary new, non-invasive diagnostic tests that may help your healthcare provider decide if your prostate cancer is in fact low risk, if something more aggressive may be lurking in your prostate, or if there are hot spots in the prostate that may need to be re-evaluated upon biopsy. PCMs also can help you and your healthcare provider determine the most appropriate treatment for your cancer.
There are many factors that will make one prostate cancer marker test better suited for individual cases. Many times, individuals who have never had a biopsy or had low to intermediate grade prostate cancer (Gleason 3+3=6 or 3+4=7) diagnosed on a biopsy are well suited for blood or urine prostate cancer markers, whereas individuals who have persistently negative biopsies or a biopsy of intermediate to high grade cancer may benefit from tissue prostate cancer markers. Use this interactive questionnaire to see what tests may be right for you. Once you’ve completed the questionnaire, discuss the results with your healthcare provider. Also be sure to check out our Patient Journey section that may help you decide which test is right for you.